FDA approves Zohydro ER
Interview: Andy Chambers, M.D., associate professor of psychiatry, Indiana University School of Medicine.
Last month the FDA approved a new high-dose narcotic painkiller, Zohydro ER, against the advice of its own advisors. Zohydro ER is five to 10 times stronger than traditional opioid painkillers and does not have abuse-deterrent properties. However, the FDA argues the benefits of Zohydro ER outweigh the costs.